Show 1493: How Doctors Are Changing the Odds Against Breast & Prostate Cancer
From The People's Pharmacy · · 1 hr 3 min
This plays from the publisher's own server. We do not host a copy.
Description
Breast cancer is the most common cancer affecting women, while prostate cancer is the most common for men. In 2022, the CDC found that approximately 255,000 men got a prostate cancer diagnosis. The same year, doctors diagnosed nearly 280,000 women with breast cancer. Breast & prostate cancer affect different patient populations and different parts of the body. Nonetheless, doctors have found common themes in diagnosing and treating these malignancies. We’ll learn how they are changing the odds.
At The People’s Pharmacy, we strive to bring you up‑to‑date, rigorously researched insights and conversations about health, medicine, wellness and health policies and health systems. While these conversations intend to offer insight and perspective, the content is provided solely for informational and educational purposes. Please consult your healthcare provider before making any changes to your medical care or treatment.
How You Can Listen
You could listen through your local public radio station or get the live stream at 7 am EST on Saturday, October 31, 2026, through your computer or smart phone (wunc.org (https://www.wunc.org)). Here is a link (https://www.peoplespharmacy.com/find-a-radio-station) so you can find which stations carry our broadcast. If you can’t listen to the broadcast, you may wish to hear the podcast later. You can subscribe through your favorite podcast provider, download the mp3 using the link at the bottom of the page, or listen to the stream on this post starting on Nov. 2, 2026.
Changing the Odds Against Breast & Prostate Cancer
Over the course of a lifetime, one in eight American women will get a breast cancer diagnosis. The odds for prostate cancer in men are similar. So are the chances of dying from these conditions: one in 43 women die of breast cancer. One in 44 men die of prostate cancer. How are oncologists changing the odds to improve survival from breast & prostate cancer?
Better Screening
The first step in controlling a condition is diagnosis. Screening techniques for breast & prostate cancer differ because breasts are easier to image. That’s why doctors prescribe mammograms to detect early signs of breast cancer.
Screening for prostate cancer starts with a blood test for prostate-specific antigen (PSA). Although it is imperfect, middle-aged men should find it a fairly easy first step. If the PSA turns up something alarming, doctors will probably proceed to order imaging, in this case an MRI of the prostate. An MRI reveals prostate tumors with greater accuracy than the old-fashioned unguided prostate biopsy could. A biopsy may still be needed as part of the diagnosis, but it is more likely to be guided by imaging, either MRI or ultrasound, than in previous decades.
Screening Controversies
Over the past few decades, public health experts have scrutinized screening in an effort to limit overdiagnosis. For several years, the United States Preventive Services Task Force (USPSTF) advised doctors against ordering PSA tests for men without symptoms. However, that approach led to more men being diagnosed at advanced stages of prostate cancer. These are more difficult to treat effectively. Now, men diagnosed with an early stage of cancer that does not require urgent treatment may be offered active surveillance. They are screened on a regular basis, and if the cancer starts to progress, the doctor offers surgery, radiation, chemotherapy or other treatment.
Mammography has also seen some controversy. Sometimes doctors disagree about when women should have their baseline mammogram and how often these should be done. Dr. Anders treats breast cancer patients. She recommends women start at age 40 and undergo mammograms every year.
Causes of Breast & Prostate Cancer
When we asked our guest experts about the causes of these cancers, they suggested that diet and lifestyle contribute. They also emphasized the importance of genetics. BRCA1 and BRCA2 gene mutations are well known for their role in elevating…